Clinical Outcomes of a Prosthetic Capsular Bag for Scleral Fixation of an Intraocular Lens in Eyes without Capsular Support
Long Bridge Medical publishes first-in-human results of its prosthetic capsular bag (PCB) for sutureless secondary IOL fixation. The study demonstrates favorable safety, stable fixation, and strong visual and refractive outcomes through 12 months.
Long Bridge Medical Receives Clearance from FDA to Initiate the U.S. Pivotal Clinical Study for LensOne Prosthetic Capsular Bag
Long Bridge Medical, Inc. today announced that the U.S. FDA has approved its IDE application for the LensOne™.
Secondary IOL Implantation Without Capsular Support
This peer-reviewed publication in the American Journal of Ophthalmology presents findings on the LensOne prosthetic capsular bag platform developed by Long Bridge Medical.
Long Bridge Medical Presents LensOne™ Around the Globe
Long Bridge Medical presents the LensOne device and study outcomes in Australia, Italy and Hong Kong.
It’s All in the Bag: Prosthetic Capsular Bag Could Transform IOL Implantation
In a Fall 2025 feature published in Retina Times, the official publication of the American Society of Retina Specialists, Block Time editors Jason Hsu, MD, and Sonia Mehta, MD, interviewed three leading vitreoretinal surgeons about Long Bridge Medical’s prosthetic capsular bag and the LensOne platform.
Long Bridge Medical Gives First Public Talks in the US
Long Bridge Medical presented the LensOne device and long-term patient outcomes at talks in Colorado, California, Florida, and Utah.
LensOne™ Awarded Breakthrough Designation
Long Bridge Medical’s LensOne device is awarded FDA’s Breakthrough Designation, identifying it as an innovative device providing it with expedited pathways to clinical and regulatory approval.
Successful First-In-Human Implantation of LensOne™ Device in Sydney, Australia
Long Bridge Medical reaches Key Milestone with Successful First-In-Human Implantation of LensOne™ Device at Sydney Eye Hospital.